Southoz , I have read your view/critique of the abstract with...

Southoz , I have read your view/critique of the abstract with high regard ,I am somewhat troubled , you say management are overly optimistic in their spin, you could be right? PRR saying Can3 demonstrates clinically meaningful benefit ? maybe they have submitted results and the FDA acts accordingly and hence the announcement ,FDA fast-tracks the approval process , If Gray says "warrants further investigation" that is good ,if it did not , trial dusted ,it is great to have someone as knowledgeable as you on this site deciphering clinical information but the dilemma is someone is stretching the results to suit ? management credibility? that's the disappointing part if correct, PRR has tanked accordingly, lets hope the facts come soon, cheers